BUY Epigral Limited — Nagaraj Shetty, HDFC Securities
byNagaraj Shetty, HDFC SecuritiesHorizon: Swing (≤2wk)23 Jul 2026via NDTV Profit (Live)
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
2 other SEBI-registered advisors have active swing BUY calls on this stock, all issued in the last 14 days
Advisor consensus · same horizon·24 Jul · today
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Epigral
- BUY — Rajesh Satpute24 Jul 2026 · ~2 weeks · target ₹1,235 · SL hit
- BUY — Nagaraj Shetty, HDFC Securities23 Jul 2026 · ~2 weeks · target ₹1,205 · Target hit
- BUY — Emkay Global6 May 2025 · ~1 year · target ₹2,450 · Expired
- BUY — Emkay Global1 Jul 2024 · ~1 year · target ₹2,000 · Target hit
More from Nagaraj Shetty, HDFC Securities
- BUY Cyient30 Sept 2026 · ~3 months · target ₹1,185 · Active
- SELL Max Healthcare Institute30 Sept 2026 · ~3 months · target ₹870 · Active
- SELL Delhivery30 Sept 2026 · ~3 months · target ₹370 · Active
- BUY Syrma SGS Technology30 Sept 2026 · ~2 weeks · target ₹1,950 · Active
- BUY Tega Industries30 Sept 2026 · ~2 weeks · target ₹2,180 · Active

